Yuting Deng

Dr. Yuting Deng is a co-founder of Chemia Biosciences Inc and a researcher in the Computational Biology Department at Carnegie Mellon University. She focuses on the integration of machine learning with metabolomics and has made significant contributions in the field of natural product synthesis. She co-developed the Seq2PKS algorithm, which leverages large-scale genomic and mass spectrometry data to predict polyketide chemical structures, significantly improving prediction accuracy. Her research spans bioinformatics and drug development, aiding in the discovery of potential therapeutics for emerging antibiotic resistance crises and future pandemics.

• Present·Chemia Biosciences Inc·Co-Founder
  • Responsible for technology development and company operations, driving innovative applications of computational biology.
• 2020–Present·Computational Biology Department, Carnegie Mellon University·Researcher
  • Developed the Seq2PKS algorithm to enhance polyketide chemical structure prediction by integrating machine learning with mass spectrometry data.

• 2015–2020·Carnegie Mellon University·Ph.D.
  • Focused on applying computational biology and machine learning to natural product synthesis.